E.U. medicines agency relaxes data-sharing rules | Higher Education and academic research | Scoop.it

Researchers remain concerned about other possible restrictions.

Academics breathed a cautious sigh of relief when the European Medicines Agency (EMA) announced yesterday that it would soften controversial draft rules to open clinical trial data to public scrutiny. In particular, the agency says it will let researchers “download, save and print the trial data for academic and non-commercial research purposes.” A previous plan would have allowed them only to view data on their computer screens. (...) - by Tania Rabesandratane, Science, 13 June 2014